Tolerance of intraoperative hemoglobin decrease during cardiac surgery

Transfusion

Volumn 54, Issue 1, 2014, Pages 2696-2704

  Hogervorst, Esther ^a   Rosseel, Peter ^b   Van Der Bom, Johanna ^a   Bentala, Mohamed ^b   Brand, Anneke ^a   Van Der Meer, Nardo ^b   Van De Watering, Leo ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ADVERSE OUTCOME; AGED; ANEMIA; ARTICLE; CEREBROVASCULAR ACCIDENT; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; BLOOD TRANSFUSION; COMORBIDITY; METABOLISM; MIDDLE AGED; OPERATIVE BLOOD LOSS; STATISTICAL MODEL;

AGED; ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; COMORBIDITY; FEMALE; HEMOGLOBINS; HOSPITAL MORTALITY; HUMANS; INTRAOPERATIVE PERIOD; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; RENAL INSUFFICIENCY; STROKE;

EID: 84908469741     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12654     Document Type: Article

References (32)

1. Munoz M, Ariza D, Gomez-Ramirez S, et al. Preoperative anemia in elective cardiac surgery: prevalence, risk factors, and influence on postoperative outcome. Transfus Altern Transfus Med 2010; 11: 47-56.
2. Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007; 116: 471-479.
3. van Straten AH, Hamad MA, van Zundert AJ, et al. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population. Circulation 2009; 120: 118-125.
4. Ranucci M, Baryshnikova E, Castelvecchio S, et al. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 2013; 96: 478-485.
5. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559-1567.
6. Marik PE, Corwin HL,. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008; 36: 2667-2674.
7. Karkouti K, Wijeysundera DN, Yau TM, et al. The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. Transfusion 2008; 48: 666-672.
8. World Health Organization. Worldwide prevalence of anaemia 1993-2005. Geneva: WHO; 2008.
9. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208.
10. Dutch Institute for Healthcare Improvement (CBO). Allogeneic blood transfusion guideline. Utrecht, The Netherlands: Dutch Institute for Healthcare Improvement; 2004.
11. Koetsier A, Peek N, de Keizer N,. Identifying types and causes of errors in mortality data in a clinical registry using multiple information systems. Stud Health Technol Inform 2012; 180: 771-775.
12. Zalpuri S, Middelburg RA, van de Watering L, et al. Association vs. causality in transfusion medicine: understanding multivariable analysis in prediction vs. etiologic research. Transfus Med Rev 2013; 27: 74-81.
13. Donders AR, van der Heijden GJ, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006; 59: 1087-1091.
14. Boston University School of Public Health. Multivariable methods. 2013. [cited 2014 Mar 27]. Available from: http://sphweb.bumc.bu.edu/otlt/MPH-Modules/BS/BS704-Multivariable/BS704-Multivariable7.html
15. VanderWeele TJ,. On the distinction between interaction and effect modification. Epidemiology 2009; 20: 863-871.
16. Isosu T, Obara S, Hosono A, et al. Validation of continuous and noninvasive hemoglobin monitoring by pulse CO-oximetry in Japanese surgical patients. J Clin Monit Comput 2013; 27: 55-60.
17. Joseph B, Hadjizacharia P, Aziz H, et al. Continuous noninvasive hemoglobin monitor from pulse ox: ready for prime time? World J Surg 2013; 37: 525-529.
18. Hare GM, Freedman J, David MC,. Review article: risks of anemia and related management strategies: can perioperative blood management improve patient safety? Can J Anaesth 2013; 60: 168-175.
19. Shander A, Javidroozi M, Ozawa S, et al. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107 (Suppl 1): i41-59.
20. Hare GM, Tsui AK, McLaren AT, et al. Anemia and cerebral outcomes: many questions, fewer answers. Anesth Analg 2008; 107: 1356-1370.
21. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279: 217-221.
22. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555-1562.
23. Hebert PC, Wells G, Martin C, et al. A Canadian survey of transfusion practices in critically ill patients. Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit Care Med 1998; 26: 482-487.
24. Banbury MK, Brizzio ME, Rajeswaran J, et al. Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg 2006; 202: 131-138.
25. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-1507.
26. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013; 165: 964-971.
27. Goodnough LT,. Transfusion triggers. Surgery 2007; 142 (4 Suppl): S67-70.
28. Schiferer A, Panzer S, Reesink HW, et al. Red cell transfusion in elective cardiac surgery patients. Vox Sang 2009; 97: 172-182.
29. DeFoe GR, Ross CS, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001; 71: 769-776.
30. Habib RH, Zacharias A, Schwann TA, et al. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg 2003; 125: 1438-1450.
31. Swaminathan M, Phillips-Bute BG, Conlon PJ, et al. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003; 76: 784-791.
32. Loor G, Li L, Sabik JF III, et al. Nadir hematocrit during cardiopulmonary bypass: end-organ dysfunction and mortality. J Thorac Cardiovasc Surg 2012; 144: 654-662.